Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.
about
Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal modelApplications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapyA New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-GuérenRecombinant Mycobacterium bovis BCG as an HIV vaccine vector.Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.Vaxvec: The first web-based recombinant vaccine vector database and its data analysisRecombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice.A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniaeSystemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium.Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guérin expressing human immunodeficiency virus type 1 Gag.The use of directed evolution to create a stable and immunogenic recombinant BCG expressing a modified HIV-1 Gag antigenPneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection.Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responsesRecombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 typeLipoproteins of bacterial pathogens.Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in miceDevelopment of Streptococcus pneumoniae Vaccines Using Live VectorsGeneration of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in miceGeneration of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatisTh1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.Immunogenicity and protection studies with recombinant mycobacteria and vaccinia vectors coexpressing the 18-kilodalton protein of Mycobacterium lepraeExperimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha.Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strainGenetic control of antibody responses induced by recombinant Mycobacterium bovis BCG expressing a foreign antigenOral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG VectorsVaccination strategies for the prevention of cervical cancer.Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.Progress towards an HIV vaccine based on recombinant bacillus Calmette-Guérin: failures and challenges.Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses.Recombinant Mycobacterium smegmatis with a pMyong2 vector expressing Human Immunodeficiency Virus Type I Gag can induce enhanced virus-specific immune responses.Current status and perspectives on protein-based pneumococcal vaccines.The BCG replacement vaccine VPM1002: from drawing board to clinical trial.Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin.Progress on development of the live BCG recombinant vaccine vehicle for combined vaccine delivery.Nasal delivery of vaccines.
P2860
Q24675231-7F2C60B0-541F-4E96-A60F-CA3C776C718BQ26798372-1213BBE2-EC75-4795-962A-81D42F7F414AQ28551001-A14581B8-539D-4900-A857-F7BE241C7FF4Q30387447-2D3AAF7E-E972-47D6-8D3D-A4631F97BC93Q30418998-4D636BC5-8F3F-4D21-8DD4-66C1578D67EEQ30485791-886053B9-B73B-41F9-AA69-CDFB2B87D7FCQ30996881-56DFFACA-54B2-49F7-8AB0-59A568D55CFAQ33596979-557ED4DD-4CDD-485A-86D7-23D29529938CQ33757861-92D377D5-DC12-4741-9B31-361089C723D7Q33768306-D0182528-C36B-4CA0-B5F4-DC205FBFFE23Q33883995-DB881D17-C3E9-40B1-90B4-C73811441CA5Q33952259-0A505152-6823-46F4-8B79-89CFB9800FBCQ33975380-1B479F69-4BAC-4768-A020-21FB08F90C82Q34002019-49030ABF-7D81-4256-BCB0-DFE47B686F53Q34006372-FDF08EB6-7634-4B58-B183-793371527D58Q34116296-C59006F4-46EB-4444-A764-95B7479066F2Q34121084-127F76FA-20ED-4369-9EAB-FBEEC53249B9Q34145626-377619F8-0D22-4C8B-BC3B-3F80CE039853Q34309667-2AFDDE76-1434-494B-A522-B8A382906838Q34316015-61D7EE84-910D-4956-A09C-74AF1116BD0BQ34353428-F3520187-6003-42C6-AA60-6FC6D8EEF5B1Q35043659-9B11ADE4-A9E8-476C-82AE-D1A51BCD45F0Q35160697-14AE840D-07FA-4A59-8678-A7AA3BE2A99AQ35215350-2789E803-1A78-42A2-9EA4-6191367BD473Q35499788-6ECCBAE4-61C9-4F54-9842-E78A8FA12894Q35515698-9F66516E-E6B3-4789-A2C9-EB8731CFF713Q35551627-B837B9B8-71B6-4784-92B1-E97867E83059Q35552033-A38B9B0C-16BD-4D29-875B-63018B6492CFQ35567265-CFE7D47C-A8CA-451E-ABDA-1C5CA49EF371Q35773904-974E8686-82C1-459C-BC5A-FADB8691D3FCQ36066161-28A1B44E-FFAE-49C1-9869-C5E002C2CC9AQ36404193-552751FC-E9D0-4094-A605-77CB4F9C0D9FQ36690291-D5F2B95E-D24D-4F94-9AD9-20A8339BF3F2Q37191912-03DE9902-511F-4FAE-A354-D8F342313848Q37704447-BDA4E67B-6E7A-441C-BE25-DD5F293C3A68Q38124921-1A6BB0C8-9B9F-48F7-851C-5CB057EBD25FQ38202181-CB4F6830-19F4-4EBE-8CA8-1000EA101AF3Q39518278-3D0F7914-DF2A-45EA-AA00-5168B9D489C6Q40985243-96A9ED94-3251-4CEA-A19E-456C90590921Q41156926-8E4CE973-3D09-4AB7-8838-8BC8F1212ABF
P2860
Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Protective humoral response ag ...... neumococcal surface protein A.
@ast
Protective humoral response ag ...... neumococcal surface protein A.
@en
type
label
Protective humoral response ag ...... neumococcal surface protein A.
@ast
Protective humoral response ag ...... neumococcal surface protein A.
@en
prefLabel
Protective humoral response ag ...... neumococcal surface protein A.
@ast
Protective humoral response ag ...... neumococcal surface protein A.
@en
P2093
P2860
P356
P1476
Protective humoral response ag ...... neumococcal surface protein A.
@en
P2093
Burlein JE
Langermann S
Palaszynski SR
P2860
P304
P356
10.1084/JEM.180.6.2277
P407
P577
1994-12-01T00:00:00Z